(EH-pih-ROO-bih-sin HY-droh-KLOR-ide)
Epirubicin hydrochloride is a type of chemotherapy drug called an anthracycline. It stops cells from copying their DNA and from making RNA and proteins. This slows or stops the growth of cancer cells and other rapidly dividing cells.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Epirubicin hydrochloride is approved to be used with other drugs to treat:
- Breast cancer. It is used after surgery in patients whose cancer has spread to the lymph nodes under the arm.
Epirubicin hydrochloride is also being studied in the treatment of other types of cancer.
More About Epirubicin Hydrochloride
Definition from the NCI Drug Dictionary – Detailed scientific definition and other names for this drug.
More About Epirubicin Hydrochloride – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Epirubicin Hydrochloride – Check for trials from NCI’s list of cancer clinical trials now accepting patients.
